Pere Domingo Pedrol

618 total citations
10 papers, 65 citations indexed

About

Pere Domingo Pedrol is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Pere Domingo Pedrol has authored 10 papers receiving a total of 65 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Virology and 4 papers in Emergency Medicine. Recurrent topics in Pere Domingo Pedrol's work include HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (4 papers). Pere Domingo Pedrol is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (4 papers). Pere Domingo Pedrol collaborates with scholars based in Spain and United States. Pere Domingo Pedrol's co-authors include Mireia Puig, José L. Casado, Juan González‐García, Albert Giralt, Asunción Hernando, Esteban Jódar Gimeno, Rebeca Reyes‐García, Estebán Martínez, Marta Mora-Rillo and Francesc Vidal and has published in prestigious journals such as Current HIV Research, Medicina Clínica and Gaceta Sanitaria.

In The Last Decade

Pere Domingo Pedrol

10 papers receiving 62 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pere Domingo Pedrol Spain 6 45 24 22 22 5 10 65
Olivier Leleux France 7 52 1.2× 44 1.8× 22 1.0× 44 2.0× 2 0.4× 14 97
Hylke Waalewijn Netherlands 4 79 1.8× 37 1.5× 41 1.9× 30 1.4× 2 0.4× 10 116
S Zaheri Netherlands 3 55 1.2× 45 1.9× 27 1.2× 22 1.0× 2 0.4× 4 79
H C Onyegbutulem Nigeria 4 67 1.5× 15 0.6× 47 2.1× 20 0.9× 3 0.6× 7 91
Katherine Shin United States 3 34 0.8× 26 1.1× 17 0.8× 26 1.2× 3 0.6× 3 62
J.G. Fuzibet France 3 60 1.3× 35 1.5× 23 1.0× 18 0.8× 2 0.4× 5 70
S. Geffard France 2 30 0.7× 19 0.8× 14 0.6× 43 2.0× 4 67
Shadrack Osei Asibey Ghana 6 23 0.5× 23 1.0× 14 0.6× 27 1.2× 8 1.6× 18 72
Giovanni Guaraldi Italy 6 51 1.1× 39 1.6× 14 0.6× 29 1.3× 2 0.4× 14 80
Siegfried Schwarze United States 2 41 0.9× 14 0.6× 23 1.0× 41 1.9× 3 0.6× 2 60

Countries citing papers authored by Pere Domingo Pedrol

Since Specialization
Citations

This map shows the geographic impact of Pere Domingo Pedrol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pere Domingo Pedrol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pere Domingo Pedrol more than expected).

Fields of papers citing papers by Pere Domingo Pedrol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pere Domingo Pedrol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pere Domingo Pedrol. The network helps show where Pere Domingo Pedrol may publish in the future.

Co-authorship network of co-authors of Pere Domingo Pedrol

This figure shows the co-authorship network connecting the top 25 collaborators of Pere Domingo Pedrol. A scholar is included among the top collaborators of Pere Domingo Pedrol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pere Domingo Pedrol. Pere Domingo Pedrol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Falcó, Vicenç, Ignacio de los Santos, Julián Olalla, et al.. (2015). Barreras para el inicio del tratamiento antirretroviral en pacientes con virus de la inmunodeficiencia humana e indicación de tratamiento en España. ¿Por qué no inician tratamiento quienes lo tienen indicado? Estudio Bridgap. Enfermedades Infecciosas y Microbiología Clínica. 33(6). 397–403. 2 indexed citations
2.
Pedrol, Pere Domingo, et al.. (2014). Executive Summary of the Consensus Statement on monitoring HIV: Pregnancy, birth, and prevention of mother-to-child transmission. Enfermedades Infecciosas y Microbiología Clínica. 32(5). 311–319. 3 indexed citations
3.
4.
Martínez, Estebán, Esteban Jódar Gimeno, Rebeca Reyes‐García, et al.. (2013). Documento de consenso: Recomendaciones para el manejo de la enfermedad ósea metabólica en pacientes con virus de la inmunodeficiencia humana. Enfermedades Infecciosas y Microbiología Clínica. 32(4). 250–258. 6 indexed citations
5.
Pérez‐Molina, José A., Marta Mora-Rillo, José L. Casado, et al.. (2010). Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 Study. Current HIV Research. 8(7). 521–530. 18 indexed citations
6.
Pedrol, Pere Domingo, et al.. (2008). Prevalencia de hipertensión arterial y perfil lipídico en pacientes con infección por el virus de la inmunodeficiencia humana. Medicina Clínica. 131(18). 681–684. 13 indexed citations
7.
Vidal, Francesc, et al.. (2008). Toxicogenética del tratamiento antirretroviral (I): lipodistrofia, alteraciones metabólicas y arteriosclerosis. Enfermedades Infecciosas y Microbiología Clínica. 26. 18–23. 4 indexed citations
8.
Pedrol, Pere Domingo, et al.. (2007). Diagnóstico tardío de la infección por el virus de la inmunodeficiencia humana en la Cohorte VACH (1997-2002). Gaceta Sanitaria. 21(1). 66–69. 7 indexed citations
9.
Amador, José Tomás Ramos, et al.. (2002). Tratamiento de la mujer embarazada infectada por el VIH. Enfermedades Infecciosas y Microbiología Clínica. 20. 29–34. 1 indexed citations
10.
Giralt, Albert, et al.. (1999). [Cardiac involvement in human immunodeficiency virus infection].. PubMed. 113(10). 383–90. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivier Leleux Breakdown of academic impact, for papers by Hylke Waalewijn Breakdown of academic impact, for papers by S Zaheri Breakdown of academic impact, for papers by H C Onyegbutulem Breakdown of academic impact, for papers by Katherine Shin Breakdown of academic impact, for papers by J.G. Fuzibet Breakdown of academic impact, for papers by S. Geffard Breakdown of academic impact, for papers by Shadrack Osei Asibey Breakdown of academic impact, for papers by Giovanni Guaraldi Breakdown of academic impact, for papers by Siegfried Schwarze
Rankless by CCL
2026